The US-based LabCorp life sciences company, whose drug development segment is known as Covance, successfully completed the acquisition of Chiltern in 2017. The aim was to strengthen their position as a global life sciences company with leading diagnostics and drug development businesses. A change of this size in a company’s life requires office expansions, change management and relocation. The two companies, Chiltern and Covance, were initially located in Allee Corner and Canada Square. Neither of these locations were able to fulfill the requirements after the merger. As a best option, the two companies decided move to a new joint location that offered a larger office area and a higher level of service and ESTON International was the partner selected to identify the new location. The optimal solution was the Residence Offices situated in District II. The property was chosen due to the excellent location, the level of service, and the leasable area, all of which perfectly suited the client. The move-in to the new 600 sq m office was completed in March 2019. The Residence Office Buildings belong to the LFPI Group that represented on the Hungarian market by FLE GmbH.